{"name":"GRIN Therapeutics, Inc.","slug":"grin-therapeutics-inc","ticker":"","exchange":"","domain":"grin.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQSllSZWJZTndQZ2pCTmRYc0VVa1dSa3VEZ0FMUldtaWp6b04wS3dwNzdSLUFoUHExXzFfRFo5cEJVUjlDZDViNmMwUno0dUxXeEUzNnB3X3BlbldRLXBibFM5ODRucnFEaERyVDF6SlZaY1VoWTdveU50OHY0a2tMQUhCN3RDUWI4LXlUdnBJNUtSSDBZVHdyamN6YVM4VnRsek9tV0VoV2NHRUpsRWNVRk1US3Z1WFNiT185aHZnZDVva0c5SFFRdGF6eVM1bWFy?oc=5","date":"2026-03-17","type":"trial","source":"TipRanks","summary":"GRIN Therapeutics Highlights Phase 3 Radiprodil Program and Angelini Pharma Partnership - TipRanks","headline":"GRIN Therapeutics Highlights Phase 3 Radiprodil Program and Angelini Pharma Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNZzM5d0c5Y0hDc1JIZVlOWmJBWFNSVTVTVlczZkhCT0tsUWpQNzJibTY2MVZmMjB2Y1puelA2bWMzdzR5cl81WHBPcjMxam9rZm9VWG1zTUFQSGk2MVQya1l6N0hTUkJZOEFGTGVudDRZMDlBVldyYkJCZTFwSXRIZGQyNVVtcTkyM010WC11cmRReGp1RGNWUDdDMW5tWFgzbDNGY3Rfc2pzV2M1LTgwSDNSbHJrbm8yc1BzNE40UQ?oc=5","date":"2026-02-24","type":"deal","source":"European Biotechnology Magazine","summary":"Angelini partners with Quiver on AI-driven discovery in genetic epilepsies - European Biotechnology Magazine","headline":"Angelini partners with Quiver on AI-driven discovery in genetic epilepsies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNVGhtMGZLQTJPYi1BaHcwWnJpbWRzNTB2OXJNbUhmMTVKb1dLbWZCdjQyRi1DNW1sOHpmNVVidElpQnhZZGR5VmxDcnhZNXB4cE91NWZoQ0hsNWdQVEtlNlhrRDlGTlFXVTdkUUk2V1RCd0RON0lJUHJyREhkYi1uZU1KN0NpR0E2ZzdqamFPOXpGdThEN3dkNks3dWtPWVFrMnFENkttbF84cVF6WXBadF9sdHhKZjB2bEhYcUp6R3RSSlA2UmFZTWd3ZzVhQzIybEFYcWVCdmc3eXhKRWNBbEZQaF9ZVEtyNzNfUXBNajAyWUZyZmdkVGVDVDd2U1dNOUVqLWU3ZW9EeEhRaGhyZlZIYk9OZlJPeGw4MTljcHplak1OYkNhSEdkY0FuVDQ2R2ZiRw?oc=5","date":"2026-01-09","type":"trial","source":"PR Newswire","summary":"GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder - PR Newswire","headline":"GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPQmRBZ29DRDJSem5HbXJyMWJJLXJVWV9YT1F2eDlsVXgwQnhPd29DQ2VCZGJxc2lxOU5Gd2QtUDg1alhuMlRXMFVVdTBqemtCOE5RellTczhaRi1Rdlc5eXQzdHk4TFRPRWw1N0FFaFo3bl9oZ0U1Um1TdXh0NjZBckFNMWdVRXhzU2liWW01NkItbkx2a3QyOVRHS1YzU0c5YTBnTElvNkx5WGJkeU16R3FMNm01Qm1CN1pUVF9PSFZRMWE2eWJQaGFxN0szNFU1cVhXUXhVdE41OTQ1ODMtald1ZTRuV2Y1M0NJYWpDTnFJOG9IYTBoTTFvVXQ3azN4SVJaNnRnY0szS0ROSnhRRw?oc=5","date":"2025-12-03","type":"trial","source":"PR Newswire","summary":"GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting - PR Newswire","headline":"GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPZGhlaXJlUjZaakRneElXblcwVnhFSDQ0eVhwMTd2YlpDZEJMNkdNdHVseV9lR1h4cnI5cDZBTW9UcTB6NEJ2VkVwM2daWVdXQXVrUDhkamdiNW1zbkd2RjE5NGhUNVltTDVVTjY1SFdxZ0xVU2JLTGhYVDV3MjlzMjc0ZjV2SDlSUHZjUnlQVnFqSXlrRDB1c0dYSklIUWo4Mmc?oc=5","date":"2025-10-29","type":"deal","source":"BioWorld News","summary":"Angelini signs $550M deal for Sovargen’s ASO drug in epilepsy - BioWorld News","headline":"Angelini signs $550M deal for Sovargen’s ASO drug in epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOY29yRlBnUjB4RW1uMnZKRnNITU5xTEVrX1NKZzhGVFhQMDQzczdidDVyNklVSkdIZGF1ZTJVUG44X3RFWHl3VHJLeENwY1hyU3dCWF90ank1dlFNX0trTjFBMGRuYUxpbkFDT2tfcHMyeHBFS2dvRXhILUZOaENSMzRLR0NFd2F0bk9hXzhUUWEzV0ZjYjZsUDBMV2ZIdmE5MEUw?oc=5","date":"2025-10-18","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules - lupin.com","headline":"Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMW1jb1NCSnFLRVVINXFianoxbTd6Y1lFQ2RNNHJZVzYxb2JUczRzajdPc2d0RVQ2eDlZWENZZ1VSZkZBRUlJSGdKblFNU3ctbkV1MkI0aVdETFctUTZ6TVg0UldXaHVnWGxXcVlkaWdPNnIwa0VXRWN4cVJLYWstOXloQXIyaDNQcDAwYnRNQjVvN3AxaVdBaEt4MEhhT0MzQmc?oc=5","date":"2025-08-25","type":"pipeline","source":"NYU Langone Health","summary":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief - NYU Langone Health","headline":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPRVktd1hLd0pkOGdndGJPNXpndm1XTk5Vb3dxT1ZvZDlhU1h4NDJrNHNsaHNIRUhSbU9oNEVwM2NRRWhBbUVORXg2WGthSkVjV3EzMzR6VEVUSzQ4OTJqTllaV3JSeWNRQU1NM1ZqMFZvcW5NRmFIRzg2S0ZSdGlGZmVhYmhqalZaSm5QT3FybU9JbUx0WmlTVjJYMWpYd1ltNXVncDBoRkdiQzhiVVh4ZEtmVXNjODJHYjQxd0VZdw?oc=5","date":"2025-06-20","type":"pipeline","source":"MedCity News","summary":"Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs - MedCity News","headline":"Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxOZzhFRDNxOWJ6dkVDZlg0M2xLVEtiQmlycXhVZjBuYmlGc1NxU01wVjRaREtLUEFCSV9ZbjRsMzAzYy0yeHB4WWNteC1FQTJ4aU5FbmdSR2NoQkNKdVdLR0Q1Y3M2U2lkVTR5eXZ1MHhVNU5zZGE4NElvNTRwd1NqclM1UnVJZExfZ0I1M3o3ZVZqdlpnNUswOWxTVDVNek9HUkZyeC12SDIzU1JjRjRUUXBGdEZDOXNLdTN6TXlTQWUxOUZXUVItU1pWcG5LcG9fRlRQSkV4bXE3ckxpSG5tbmNuNmlYdGVKRDEtNV9pZnNWQkN5ejNNRm9HWnZZM3ozOExPb21nT29qV1hEUnROeHl2a0c5eHcxMWc?oc=5","date":"2025-05-27","type":"deal","source":"PR Newswire","summary":"GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America - PR Newswire","headline":"GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPd2FCbVljRnczekRvZ0xrOEp1aXAwU1N6X0FRNEk1dHFhWVE4OUpib05yX1lzSTBCUXZZaUNUcS15WTBMNWRDeTFuMFV4aWNKbmlYUDdJOWxCZEM4MGw3UlpWMHB3TVFXUzYyTDBSSnBmQXJuUVhPaUJxNEFqTWhKR0c5X2hPWUZQZXJnblExZ3ZjVDBKanYxanlPUE56VU85VGwzRXE2RzhEZmZ6cXZmSTJycVlHZE1CTTI1QllpQ2JkUQ?oc=5","date":"2025-05-27","type":"deal","source":"Contract Pharma","summary":"GRIN Therapeutics, Angelini Pharma Partner to Develop & Commercialize Radiprodil - Contract Pharma","headline":"GRIN Therapeutics, Angelini Pharma Partner to Develop & Commercialize Radiprodil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPQ3JaYlhZaFRoN0N0VnFYczRxT1BiZjNVS1Uya21KeWxjVXJ5ZFlRb2xIZ0ZmR09uanFGR1JmOVVLSGMyWVIzX0ZWTnVWc3lzRUs2YTB6endNeEhQTWZ0eEpMcVdBNTByRGNQMUtTMnFTZEVNR2Z0S1FTWjQ4LWY0RDZEQ3lBM3U1bGdmLWpxRXhQM2o3aE9jVzFNUDJYY0lScTZnUnk2QnIwTWhEOXEydkdsUVJtWmNqVlBkNXpwcWEtcTlFY0N4N18tR2dNUkE?oc=5","date":"2025-05-27","type":"pipeline","source":"Citeline News & Insights","summary":"Angelini Advances Brain Health Ambitions With GRIN Pact - Citeline News & Insights","headline":"Angelini Advances Brain Health Ambitions With GRIN Pact - Citeline News & Insights","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}